U.S. Marine and Shipping Stock News

In early July 2026, U.S. military strikes on Iranian targets and Iran’s temporary closure of the Strait of Hormuz heightened concerns about global energy supply disruptions and shipping risks. For Green Plains, this tension underscores how geopolitical shocks in critical chokepoints can quickly reshape investor perceptions of U.S.-based energy and commodity producers. Now, we’ll examine how heightened Strait of Hormuz tensions and supply security concerns may influence Green Plains’...

DuPont de Nemours (NYSE:DD) has introduced a new Direct Lithium Extraction portfolio covering the full lithium brine treatment lifecycle. The platform brings together more than 20 products, including lithium selective adsorbents, nanofiltration, and low salt rejection reverse osmosis technologies. The offering is designed to serve a broad range of global brine resources and support scalable, sustainable lithium production for batteries and energy storage. For investors following DuPont de...

Box (NYSE: BOX) has introduced new workflow automation tools for its content platform. The company is also expanding its geographic footprint by entering new markets. These product and market moves are being closely compared with offerings from DocuSign. Box enters this phase of product expansion with its shares trading around $30.0 and a mixed recent track record. The stock is up 18.2% over the past 30 days and 4.0% over the past week, while returns over 1 and 3 years have declined 6.5%...

Q32 Bio (QTTB) has completed a $200 million follow on equity offering, shortly after releasing strong 36 week topline data for its bempikibart Phase 2a SIGNAL AA trial in severe alopecia areata. See our latest analysis for Q32 Bio. Q32 Bio’s recent bempikibart data and the follow on offering come after a period of sharp share price moves, with the 7 day share price return of 35.54% and year to date share price return of 436.63% pointing to strong momentum. The 1 year total shareholder return...

Over the last 7 days, the United States market has remained flat, yet it has experienced a significant 20% increase over the past year with earnings forecasted to grow by 18% annually. In this context of overall growth, identifying stocks that are trading below their intrinsic value can present potential opportunities for investors seeking to capitalize on undervalued assets.

In the last week, the United States market has stayed flat, but it has seen a 20% increase over the past year with earnings expected to grow by 18% annually. In this context of steady growth, companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.

Over the last 7 days, the U.S. market has remained flat, though it is up 20% over the past year with earnings forecasted to grow by 18% annually. Investing in penny stocks—often associated with smaller or newer companies—can still open doors to growth opportunities when these stocks are backed by strong financial health. In this context, we will explore several penny stocks that stand out for their financial strength and potential for long-term success.

Independent Bank Corp. recently announced it would release its second-quarter 2026 earnings on July 16, with analysts expecting earnings of US$1.77–US$1.78 per share and revenue of about US$257.73–US$258.95 million. These expectations, alongside a fresh US$0.64 per-share dividend declaration and ongoing analyst estimate revisions, are sharpening investor focus on the bank’s near-term performance. We’ll now examine how the upcoming earnings release and stronger earnings expectations may...

New U.S. tariffs of 25% on thousands of Brazilian imports are set to reshape how agricultural and industrial goods move around the world, with roughly $15b in trade directly in the crosshairs. For investors, that kind of shock can quickly split stocks into potential winners and potential losers as input costs, export routes, and customer demand all adjust. This article walks through three stocks exposed to the tariff story, showing how one could find support from shifting trade flows while...

Laughing Water Capital’s recent decision to add AnaptysBio (ANAB) has drawn attention because it hinges on two factors: royalty income from the cancer drug Jemperli and an imminent commercial trial with partner GSK. See our latest analysis for AnaptysBio. Despite the recent legal spotlight, AnaptysBio’s share price has been volatile, with a 1-day share price return down 10.46% and a 7-day share price return down 7.15%. However, a year-to-date share price return of 39.07% sits alongside a very...

Sabine Royalty Trust recently reported past production results for July 2026, with oil output of 54,139 bbls and gas production of 1,074,976 Mcf, alongside a reduced monthly cash distribution of US$0.429150 per unit declared by Argent Trust Company for payment on July 29, 2026. This combination of higher reported production volumes but a lower declared distribution highlights how the trust’s payout can diverge from short-term operational trends. Next, we will examine how the reduced July...

Wells Fargo has more than doubled investors' money over the past five years, yet its current checks suggest the stock still trades at a discount, with both the intrinsic value estimate and earnings multiples pointing to potential undervaluation rather than excess optimism. A 114.5% return over five years suggests Wells Fargo has already rewarded patient shareholders, so any perceived discount now matters more for future risk and reward. Recent earnings strength and higher capital returns can...

US growth stocks are back in focus after softer US inflation data eased pressure on interest rates, energy costs steadied and fresh signals emerged from the semiconductor and AI space. For investors trying to sort potential opportunities from risks, this mix of macro news and sector stories can matter as much as any single earnings print. This article walks through 3 US growth stocks from our screener that are exposed to these catalysts, explaining how each could be helped or hurt by the...

Agenus (AGEN) is back in focus after fresh Phase 1b data on its botensilimab plus balstilimab regimen in refractory microsatellite stable metastatic colorectal cancer, as well as an oversubscribed private placement tied to its planned ROBBIN Phase 3 trial. See our latest analysis for Agenus. Agenus has been highly volatile, with the share price return up 45.1% over the past week and 57.3% year to date, but the 1 year total shareholder return is still down 18.3% and the 5 year total...

Redwire (NYSE:RDW) secured US$21.5 million in follow-on awards to supply uncrewed aircraft systems to the U.S. Marine Corps. The contracts cover additional Advanced Stalker Block 30 systems that align with the Marine Corps' ISR modernization plans. The awards extend an existing relationship, reflecting continued use of Redwire's platform in U.S. defense programs. For investors tracking Redwire, this latest contract underscores the company’s role in supplying uncrewed aircraft systems to...

After a very strong run over the past five years, Modine Manufacturing now screens as only fairly valued on a Discounted Cash Flow (DCF) intrinsic value estimate, while traditional market multiples suggest that the stock is on the expensive side. Modine Manufacturing has delivered a very large 5 year return of about 13x, which means recent buyers are stepping into a stock that has already rewarded long term holders significantly. The planned combination of Modine's Performance Technologies...

Carnival Corporation is highlighting its Alaska business as a key long-term growth driver, with a focus on integrated cruise and land experiences. The company is investing in higher-value Alaska packages, including expansion of its Denali lodge facilities. This shift positions Alaska as a central part of Carnival's broader business strategy for future expansion. Carnival (NYSE:CCL) is putting fresh emphasis on Alaska at a time when its stock trades around $26.5, with a mixed return profile...

ASML Holding (NasdaqGS:ASML) reports strong Q2 2026 results and raises its quarterly and full-year 2026 sales and margin guidance. Intel Foundry uses ASML's High NA EUV tools for production chips, marking the first high-volume output on this new lithography standard. Management cites robust AI-related demand and outlines plans for significant capacity expansion to support customers. ASML Holding sits at the center of advanced chip production, supplying lithography systems that are essential...

Vertex Pharmaceuticals (NasdaqGS:VRTX) agreed to acquire Crinetics Pharmaceuticals in a US$10b all cash transaction. The deal brings atumelnant, an advanced clinical stage drug candidate for congenital adrenal hyperplasia, into Vertex's pipeline. The acquisition marks a move by Vertex into adrenal disease therapeutics, expanding beyond its traditional focus areas. For investors following Vertex Pharmaceuticals, this deal signals a push beyond the company’s established franchises and into...

We wouldn't blame SharkNinja, Inc. ( NYSE:SN ) shareholders if they were a little worried about the fact that CJ Xuning...

We wouldn't blame Arcus Biosciences, Inc. ( NYSE:RCUS ) shareholders if they were a little worried about the fact that...

The proposed US$53b bid by Stripe and Advent International for PayPal has pushed digital payments and broader fintech back into the spotlight, with a 28% offer premium hinting at how highly some buyers value this space. For investors, that kind of interest can reshape expectations across the sector, from transaction platforms to tech driven financial services. This article looks at three fintech stocks from our Fintech Sector Stocks screener that are closely tied to this news and explains how...

Arcos Dorados Holdings has delivered a 66.4% gain over the past five years, yet current valuation work suggests the stock may still trade below its intrinsic value, even after a softer recent patch for the share price. Arcos Dorados Holdings is up 66.4% over five years, which puts the current debate squarely on whether that longer term return already reflects the value in the business. The planned redemption of the 6.125% sustainability linked senior notes can support lower interest costs...

Equity Bancshares, Inc. reported second-quarter 2026 results showing net interest income of US$73.87 million, net income of US$26.44 million, basic EPS of US$1.28, and net charge-offs of US$1.7 million, while completing a buyback of 883,707 shares for US$39.09 million. Together, the earnings strength, controlled credit costs, and completion of a multi-quarter share repurchase program highlight management’s focus on profitability and capital deployment. Next, we’ll examine how this strong...